IgM Flare in Anti-MAG Neuropathy Post Rituximab Treatment: A Clinical Case and a Systematic Review of the Literature.

Autor: Siconolfi, Giovanni¹ (AUTHOR) siconolfig@yahoo.it, Vitali, Francesca¹ (AUTHOR) vitali.francesca95@gmail.com, Sciarrone, Maria Ausilia¹ (AUTHOR) a.sciarrone97@gmail.com, Ardito, Michelangelo¹ (AUTHOR) michelangelo.ardito01@icatt.it, Guglielmino, Valeria¹ (AUTHOR) guglielmino.valeria@gmail.com, Romano, Angela¹ (AUTHOR) angela.romano12@gmail.com, Granata, Giuseppe² (AUTHOR) granata.gius@gmail.com, Silvestri, Gabriella^1,3 (AUTHOR) gabriella.silvestri@policlinicogemelli.it, Luigetti, Marco^1,3 (AUTHOR) mluigetti@gmail.com

Publikováno v: Brain Sciences (2076-3425). Dec2024, Vol. 14 Issue 12, p1294. 10p.

Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214).

Autor: Treon SP; Bing Center for Waldenstrom's Macroglobulinemia at the Dana-Farber Cancer Institute; and Harvard Medical School, Boston, Massachusetts. steven_treon@dfci.harvard.edu., Meid K; Bing Center for Waldenstrom's Macroglobulinemia at the Dana-Farber Cancer Institute; and Harvard Medical School, Boston, Massachusetts., Tripsas C; Bing Center for Waldenstrom's Macroglobulinemia at the Dana-Farber Cancer Institute; and Harvard Medical School, Boston, Massachusetts., Heffner LT; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Eradat H; Jonsson Comprehensive Cancer Center, UCLA School of Medicine, Los Angeles, California., Badros AZ; Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland., Xu L; Bing Center for Waldenstrom's Macroglobulinemia at the Dana-Farber Cancer Institute; and Harvard Medical School, Boston, Massachusetts., Hunter ZR; Bing Center for Waldenstrom's Macroglobulinemia at the Dana-Farber Cancer Institute; and Harvard Medical School, Boston, Massachusetts., Yang G; Bing Center for Waldenstrom's Macroglobulinemia at the Dana-Farber Cancer Institute; and Harvard Medical School, Boston, Massachusetts., Patterson CJ; Bing Center for Waldenstrom's Macroglobulinemia at the Dana-Farber Cancer Institute; and Harvard Medical School, Boston, Massachusetts., Gustine J; Bing Center for Waldenstrom's Macroglobulinemia at the Dana-Farber Cancer Institute; and Harvard Medical School, Boston, Massachusetts., Castillo JJ; Bing Center for Waldenstrom's Macroglobulinemia at the Dana-Farber Cancer Institute; and Harvard Medical School, Boston, Massachusetts., Matous J; Rocky Mountain Cancer Center, Denver, Colorado., Ghobrial IM; Bing Center for Waldenstrom's Macroglobulinemia at the Dana-Farber Cancer Institute; and Harvard Medical School, Boston, Massachusetts.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 May 15; Vol. 23 (10), pp. 2400-2404. Date of Electronic Publication: 2016 Nov 11.

Multiple Genomic Alterations, Including a Novel AFF4::IRF1 Fusion Gene, in a Treatment-Refractory Blastic Plasmacytoid Dendritic-Cell Neoplasm: A Case Report and Literature Review.

Autor: Sahin, Yavuz¹ (AUTHOR) yavuz.sahin@fccc.edu, Wang, Y. Lynn^1,2 (AUTHOR) yuelynn.wang@fccc.edu, Pei, Jianming^1,2 (AUTHOR) jianming.pei@fccc.edu, Mansoor, Nashwa¹ (AUTHOR) nashwa.mansoor@fccc.edu, Styler, Michael³ (AUTHOR) michael.styler@fccc.edu, Testa, Joseph R.^4,5 (AUTHOR) joseph.testa@fccc.edu, Nejati, Reza¹ (AUTHOR) reza.nejati@fccc.edu

Publikováno v: International Journal of Molecular Sciences. Jan2024, Vol. 25 Issue 1, p305. 9p.

The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis.

Autor: Hunter ZR; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA;, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Manning RJ, Tripsas C, Patterson CJ, Sheehy P, Treon SP

Publikováno v: Blood [Blood] 2014 Mar 13; Vol. 123 (11), pp. 1637-46. Date of Electronic Publication: 2013 Dec 23.

MYD88 Wild Type in IgM Monoclonal Gammopathies: From Molecular Mechanisms to Clinical Challenges.

Autor: Bagratuni, Tina¹ (AUTHOR) apapadimou@med.uoa.gr, Papadimou, Alexandra¹ (AUTHOR), Taouxi, Kostantina¹ (AUTHOR), Dimopoulos, Meletios A.¹ (AUTHOR), Kastritis, Efstathios¹ (AUTHOR)

Publikováno v: Hemato. Sep2023, Vol. 4 Issue 3, p259-272. 14p.